Alstonia scholaris, commonly known as devil’s tree is an important medicinal plant in the various folk and traditional systems of medicine in Asia, Australia, and Africa. The decoction, mostly prepared from the bark, is used to treat a variety of diseases of which the most important is malaria. Furthermore, ethnomedicinal practices also suggest it to be of use in treating cancer, and preclinical studies performed with cultured neoplastic cells and tumor-bearing animals having validated these observations. Additionally, the phytochemicals like echitamine, alstonine, pleiocarpamine, O-methylmacralstonine, macralstonine, and lupeol are also reported to possess antineoplastic effects. In addition to the cytotoxic effects, A scholaris is also observed to possess radiomodulatory, chemomodulatory, and chemopreventive effects and free-radical scavenging, antioxidant, anti-inflammatory, antimutagenic, and immunomodulatory activities, all of which are properties efficacious in the treatment and prevention of cancer. The current review for the first time summarizes the results related to these properties. An attempt is also made to address the lacunae in these published studies and emphasize aspects that need further investigations for it to be of use in clinics in the future.
World Health Organization.WHO Traditional Medicine Strategy 2002-2005. Geneva, Switzerland: World Health Organization; 2002 . World Health Organization Document, WHO/EDM/TRM/2002.1.
2.
Mukherjee PK , Wahile A.Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J Ethnopharmacol . 2006;103:25-35.
3.
Arulmozhi S. , Mitra-Mazumder P., Ashok P., et al. Pharmacological activities of Alstonia scholaris Linn (Apocynaceae): a review. Phcog Rev. 2007;1:163-170.
4.
Anonymous.Wealth of India: Raw Materials. Vol 43. New Delhi, India: Council of Scientific and Industrial Research; 1960.
Arulmozhi S. , Mitra-Mazumder P., Ashok P., et al. In vitro antioxidant and free radical scavenging activity of Alstonia scholaris Linn. R.Br. Iran J Pharmacol Ther. 2008;6:1991-1996.
12.
Cai XH, Du ZZ, Luo XDUnique monoterpenoid indole alkaloids from Alstonia scholaris. Org Lett. 2007;9:1817-1820.
13.
Hui T., Sun Y., Zhu L., Guo W., Rao G.Flavonoids in leaves of Alstonia scholaris. Zhongguo Zhong Yao Za Zhi. 2009;34: 1111-1113.
14.
Rastogi RM, Mehrotra BNCompendium of Indian Medicinal Plants. Lucknow , India: Central Drug Research Institute; 1990 .
15.
World Cancer Research Fund/ American Institute for Cancer Research.Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: American Institute for Cancer Research ; 2007.
16.
DeVita VT , Lawrence TS, Hellman A., Rosenberg SACancer: Principles & Practice of Oncology . 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2004.
17.
Dorr RT, Fritz WLCellular Chemotherapy Consideration in Cancer Chemotherapy: Hand Book . London, UK: Henry Klimpton;1980 .
18.
Graham JG, Quinn ML, Fabricant DS, et al. Plants used against cancer: an extension of the work of Jonathan Hartwell. J Ethnopharmacol. 2000;73:347-377.
19.
Baliga MSEvaluation of the Antineoplastic and Radiosensitizing Activities of Sapthaparna (Alstonia scholaris) In Vivo and In Vitro [doctoral dissertation] . Manipal, India: Kasturba Medical College, Manipal University ; 2003.
20.
Jagetia GC, Baliga MSThe effect of seasonal variation on the antineoplastic activity of Alstonia scholaris R.Br, in HeLa cells. J Ethnopharmacol. 2005;96:37-42.
21.
Jagetia GC, Baliga MSEvaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (sapthaparna) in vitro and in vivo. Phytother Res . 2006;20:103-109.
22.
Keawpradub N., Houghton PJ, Eno-Amooquaye E., Burke PJActivity of extracts and alkaloids of Thai Alstonia species against human lung cancer cell lines . Planta Med. 1997;63:97-101.
23.
Jagetia GC, Baliga MS, Venkatesh P., et al. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice. J Pharm Pharmacol. 2005;57:1213-1219.
24.
Kamarajan P. , Sekar N., Mathuram V., Govindasamy S.Antitumor effect of echitamine chloride on methylcholonthrene induced fibrosarcoma in rats. Biochem Int . 1991;25:491-498.
25.
Kamarajan P. , Ramamurthy N., Govindasamy S.In vitro evaluation of the anticancer effects of echitamine chloride on fibrosarcoma cells. J Clin Biochem Nutr. 1995;18:65-71.
26.
Saraswathi V., Ramamoorthy N., Subramaniam S., et al. Enhancement of the cytotoxic effects of echitamine chloride by vitamin A: an in vitro study on Ehrlich ascites carcinoma cell culture. Indian J Pharmacol. 1997;29:244-249.
27.
Saraswathi V., Ramamoorthy N., Subramaniam S., Mathuram V., Gunasekaran P., Govindasamy S.Inhibition of glycolysis and respiration of sarcoma-180 cells by echitamine chloride . Chemotherapy. 1998;44:198-205.
28.
Saraswathi V., Shyamala AC, Mathuram V., Subramanian S., Govindasamy S.Studies on the effect of echitamine chloride on serum glycoproteins and lysosomal hydrolases of sarcoma-180 induced mice . Fitoterapia. 1998;1:73-76.
29.
Saraswathi V., Mathuram V., Subramanian S., Govindasamy S.Modulation of the impaired drug metabolism in sarcoma-180-bearing mice by echitamine chloride. Cancer Biochem Biophys. 1999;1:79-88.
30.
Beljanski M. , Beljanski MSSelective inhibition of in vitro synthesis of cancer DNA by alkaloids of beta-carboline class. Exp Cell Biol. 1982;50:79-87.
31.
Beljanski M. , Beljanski MSThree alkaloids as selective destroyers of cancer cells in mice: synergy with classic anticancer drugs. Oncology. 1986;43:198-203.
32.
Saleem M., Maddodi N., Abu Zaid M., et al. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res. 2008;14:2119-2127.
33.
Hata K., Hori K., Murata J., Takahashi S.Remodeling of actin cytoskeleton in lupeol-induced B16 2F2 cell differentiation . J Biochem. 2008;138:467-472.
34.
Saleem M., Kaur S., Kweon MH, Adhami VM, Afaq F., Mukhtar H.Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway . Carcinogenesis. 2005;26:1956-1964.
35.
Prasad S., Madan E., Nigam N., Roy P., George J., Shukla Y.Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/ PKB and NFkβ signaling pathways . Cancer Biol Ther. 2009;8: 1632-1639.
36.
Zhang L., Zhang Y., Zhang L., Yang X., Lv Z.Lupeol, a dietary triterpene, inhibited growth, and induced apoptosis through down-regulation of DR3 in SMMC7721 cells. Cancer Invest . 2009;27:163-170.
37.
Saleem M., Kweon MH, Yun JM, et al. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res. 2005;65:11203-11213.
38.
Saleem M., Murtaza I., Tarapore RS, et al. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis. 2009;30:808-817.
39.
Prasad S., Nigam N., Kalra N., Shukla Y.Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells . Mol Carcinog. 2008;47:916-924.
40.
Hall EJRadiobiology for the Radiologist. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2005.
41.
Dorr RTChemoprotectants for cancer chemotherapy. Semin Oncol . 1991;18:48-58.
42.
Calabresi P. , Parks R.Alkylating agents, antimetabolites, hormones, and other antiproliferative agents. In: Goodman LS, Gilman A, eds. Pharmacologic Basis of Therapeutics . Toronto, ON, Canada: Macmillan ; 1999:1348-1359.
43.
Jagetia GC, Baliga MSModulation of antineoplastic activity of cyclophosphamide by Alstonia scholaris in Ehrlich ascites carcinoma-bearing mice. J Exp Ther Oncol . 2003;3:272-282.
44.
Sudharsan PT , Mythili Y., Selvakumar E., Varalakshmi P.Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress. Hum Exp Toxicol . 2005;24:313-318.
45.
Sudharsan PT , Mythili Y., Sudhahar V., Varalakshmi P.Role of lupeol and its ester on cyclophosphamide-induced hyperlipidaemic cardiomyopathy in rats. J Pharm Pharmacol . 2005;57:1437-1444.
46.
Sudharsan PT , Mythili Y., Selvakumar E., Varalakshmi P.Lupeol and its ester ameliorate the cyclophosphamide provoked cardiac lysosomal damage studied in rat. Mol Cell Biochem. 2006 ;282:23-29.
47.
Sudharsan PT , Mythili Y., Selvakumar E., Varalakshmi P.Lupeol and its ester exhibit protective role against cyclophosphamide-induced cardiac mitochondrial toxicity. J Cardiovasc Pharmacol. 2006;47:205-210.
48.
Sudharsan PT , Mythili Y., Selvakumar E., Varalakshmi P.Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats. Mol Cell Biochem. 2006 ;292:39-44.
49.
Jagetia GC, Baliga MSTreatment with Alstonia scholaris enhances radiosensitivity in vitro and in vivo. Cancer Biother Radiopharm. 2003 ;18:917-929.
50.
Gupta U., Jahan S., Chaudhary R., Goyal PKAmelioration of radiation-induced hematological and biochemical alterations by Alstonia scholaris (a medicinal plant) extract. Integr Cancer Ther. 2008;7:155-161.
51.
Guilford JM , Pezzuto JMNatural products as inhibitors of carcinogenesis . Expert Opin Investig Drugs. 2008;17: 1341-1352.
52.
Jagetia GC, Baliga MS, Venkatesh P.Effect of sapthaparna (Alstonia scholaris Linn.) in modulating the benzo(a) pyrene-induced forestomach carcinogenesis in mice. Toxicol Lett. 2003;144:183-193.
53.
Jahan S., Chaudhary R., Goyal PKAnticancer activity of an Indian medicinal plant, Alstonia scholaris, on skin carcinogenesis in mice. Integr Cancer Ther. 2009;8:273-279.
54.
Saleem M., Afaq F., Adhami VM, Mukhtar H.Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene. 2004;23:5203-5214.
55.
Nigam N., Prasad S., Shukla Y.Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food Chem Toxicol. 2007;45:2331-2335.
56.
Nigam N., Prasad S., George J., Shukla Y.Lupeol induces p53 and cyclin-B-mediated G2/M arrest and targets apoptosis through activation of caspase in mouse skin. Biochem Biophys Res Commun. 2009;381:253-258.
57.
Rajic A., Kweifio-Okai G., Macrides T., Sandeman RM, Chandler DS, Polya GMInhibition of serine proteases by anti-inflammatory triterpenoids . Planta Med. 2000;66:206-210.
58.
Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RDFree radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India . 2004; 52:794-804.
59.
Arulmozhi S. , Mitra-Mazumder P., Ashok P., Hulkoti B., Narayanan LSAntinociceptive and anti-inflammatory activities of Alstonia scholaris Linn. R.br. Phcog Mag. 2007;3: 106-111.
60.
Jagetia GC, Baliga MSThe evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study. J Med Food . 2004;7:343-348.
61.
Shang JH, Cai XH, Feng T., et al. Pharmacological evaluation of Alstonia scholaris: Anti-inflammatory and analgesic effects. J Ethnopharmacol. 2010 ;129:174-181.
62.
Lim-Sylianco CY, Jocano AP, Linn CMAntimutagenicity of twenty Philippine plants using the micronucleus test in mice. Philipp J Sci. 1990;117:231-235.
63.
Lin SC, Lin CC, Lin YH, Supriyatna S., Pan SLThe protective effect of Alstonia scholaris R.Br. on hepatotoxin-induced acute liver damage. Am J Chin Med. 1996;24:153-164.
64.
Spelman K., Burns J., Nichols D., Winters N., Ottersberg S., Tenborg M.Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006;11:128-150.
Baliga MS, Jagetia GC, Ulloor JN, et al. The evaluation of the acute toxicity and long term safety of hydroalcoholic extract of sapthaparna (Alstonia scholaris) in mice and rats . Toxicol Lett. 2004;151:317-326.
67.
Jagetia GC, Baliga MSInduction of developmental toxicity in mice treated with Alstonia scholaris (sapthaparna) in utero. Birth Defects Res B Dev Reprod Toxicol . 2003;68:472-478.
